Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Jun 25, 2026, 4:00 PM EDT
1.121
-0.009 (-0.76%)
After-hours: Jun 25, 2026, 7:32 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $69.44 million as of June 25, 2026. Its market cap has decreased by -26.55% in one year.
Market Cap
69.44M
Enterprise Value
-72.67M
1-Year Change
-26.55%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $69.44M, a decrease of -90.59%. That is a compound annual growth rate of -32.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 69.44M | -7.38% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 76.30M |
| Elicio Therapeutics | 75.61M |
| Gain Therapeutics | 75.50M |
| Annovis Bio | 74.02M |
| MindWalk Holdings | 74.00M |
| Veraxa Biotech AG | 73.38M |
| XBiotech | 71.04M |
| Acrivon Therapeutics | 69.77M |